Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites

Journal of Hepatology

Volumn 26, Issue 6, 1997, Pages 1372-1378

  Guarner, Carlos ^a   Runyon, Bruce A ^a   Young, Sharon ^a   Heck, Mary ^a   Sheikh, M Yasin ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Bacterial translocation; Cirrhosis; Intestinal bacterial overgrowth; Spontaneous bacterial peritonitis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES; BACTERIAL COUNT; BACTERIAL OVERGROWTH; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; FECES ANALYSIS; INTESTINE FLORA; LIVER CIRRHOSIS; MALE; MESENTERY LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030874289     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80474-6     Document Type: Article

References (46)

1. Berg RD. Bacterial translocation from the gastrointestinal tract. J Med. 23:1992;217-244.
2. Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol. 21:1994;792-796.
3. Llovet JM, Bartoli R, Planas R, Cabre E, Jimenez M, Urban A, Ojanguren I, Arnal J, Gassull MA. Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis. Gut. 35:1994;1648-2.
4. Garcia-Tsao G, Lee F-Y, Barden GE, Cartun R, West AB. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology. 108:1995;1835-1841.
5. Sedman B, MacFie J, Sagar P, Mitchell CJ, May J, Mancey-Jones B, Johnstone D. The prevalence of gut translocation in humans. Gastroenterology. 107:1994;643-649.
6. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology. 4:1984;53-58.
7. Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology. 8:1988;632-635.
8. Rajkovic IA, Williams R. Abnormalities of neutrophil phagocytosis, intracellular killing, and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology. 6:1986;252-262.
9. Balthazar EJ, Gade MF. Gastrointestinal edema in cirrhotics. Gastrointest Radiol. 1:1976;215-223.
10. Normal DA, Atkins JM, Seelig LL, Gomez-Sanchez C, Krejs GJ. Water and electrolyte movement and mucosal morphology in the jejunum of patients with portal hypertension. Gastroenterology. 79:1980;707-715.
11. Sorell WT, Quigley EMM, Jin G, Johnson TJ, Rikkers LF. Bacterial translocation in the portal-hypertensive rat: studies in basal conditions and on exposure to hemorrhagic shock. Gastroenterology. 104:1993;1722-1726.
12. Garcia-Tsao G, Albillos A, Barden GE, West AB. Bacterial translocation in acute and chronic portal hypertension. Hepatology. 17:1993;1081-1085.
13. Deitch EA, Ma W-J, Ma L, Berg R, Specian RD. Endotoxin-induced bacterial translocation: a study of mechanisms. Surgery. 106:1989;292-299.
14. Deitch EA, Specian RD, Berg RD. Endotoxin-induced bacterial translocation and mucosal permeability: role of xanthine oxidase, complement activation, and macrophage products. Crit Care Med. 19:1991;785-791.
15. Walker RI. The contribution of endotoxin to mortality in hosts with compromised resistance: A review. Exp Hematol. 6:1978;172-177.
16. Morrison DC, Ryan JL. Bacterial endotoxins and host immune responses. Adv Immunol. 28:1979;293-450.
17. Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology. 8:1988;232-236.
18. Guarner C, Soriano G, Tomas A, Bulbena O, Novella M, Balanzo J, Vilardell F, Mourelle M, Moncada S. Increased serum nitrite and nitrate in patients with cirrhosis of the liver: relationship to endotoxemia. Hepatology. 18:1993;1139-1143.
19. Martini GA, Phear EA, Ruebner B, Sherlock S. The bacterial content of the small intestine in normal and cirrhotic subjects: relation to methionine toxicity. Clin Sci. 16:1957;35-51.
20. Lal D, Gorbach S, Levitan R. Intestinal microflora in patients with alcoholic cirrhosis: urea splitting bacteria and neomycin resistance. Gastroenterology. 62:1972;275-279.
21. Bode JC, Bode C, Heidelbach R, Durr K, Martini GA. Jejunal microflora in patients with chronic alcohol abuse. Hepatogastroenterology. 31:1984;30-34.
22. Shindo K, Yamazaki R, Shionoiri H. Evidence of cirrhotic patients with positive bile acid breath test. Curr Ther. 46:1989;643-647.
23. Chesta J, Silva M, Thompson L, Del Canto E, Defilippi C. Small intestinal bacterial overgrowth in patients with hepatic cirrhosis. Rev Med Chil. 119:1991;626-632.
24. Chesta J, Defilippi C, Defilippi C. Abnormalities in proximal small bowel motility in patients with cirrhosis. Hepatology. 17:1993;828-832.
25. Casafont F, de las Heras G, Martin L, Lopez MJ, Ledesma F, Pons F. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci. 40:1995;1252-1256.
26. Runyon BA, Borzio M, Young S, Squier SU, Guarner C, Runyon M. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis. Hepatology. 21:1995;1719-1724.
27. Gines P, Rimola A, Planas R, Vargas V, Marco F, Almeda M, Forne M, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology. 12:1990;716-724.
28. Soriano G, Guarner C, Teixido M, Such J, Barrios J, Enriquez J, Vilardell F. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology. 100:1991;477-481.
29. Soriano G, Guarner C, Tena F, Villanueva C, Fabrega E, Gonzalez D, Sainz S, Espinos J, Balanzo J, Vilardell F. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal bleeding. Gastroenterology. 103:1992;1267-1272.
30. Singh N, Gayowski T, Yu VL, Wagener MM. Trimethoprimsulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Intern Med. 122:1995;595-598.
31. Runyon BA, Sugano S, Kanel G, Mellencamp MA. A rodent model cirrhosis, ascites and bacterial peritonitis. Gastroenterology. 100:1991;489-493.
32. Gautreaux MD, Deitch EA, Berg RD. Bacterial translocation from the gastrointestinal tract to various segments of the mesenteric lymph node complex. Infect Immun. 62:1994;2132-2134.
33. Hoefs JC, Runyon BA. Spontaneous bacterial peritonitis. Disease-a-Month. 31:1985;1-48.
34. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol. 18:1993;271-272.
35. Runyon BA. Bacterial infections in patients with cirrhosis. J Hepatol. 18:1993;271-272.
36. Moody FG, Haley-Russell DH, Muncy DM. Intestinal transit and bacterial translocation in obstructive pancreatitis. Dig Dis Sci. 40:1995;1798-1804.
37. Wang X-D, Guo W-D, Andersson R, Ekblad E, Soltesz V, Bengmark S. The association between enteric bacterial overgrowth and gastrointestinal motility after subtotal liver resection or portal vein obstruction in rats. Eur J Surg. 160:1994;153-160.
38. Reilly JA Jr., Quigley EMM, Forts CF, Rikkers LF. Small intestinal transit in the portal hypertensive rat. Gastroenterology. 100:1996;670-674.
39. Wegener M, Schaffstein J, Dilger U, Coenen C, Wedmann B, Schmidt G. Gastrointestinal transit of solid-liquid meal in chronic alcoholics. Dig Dis Sci. 36:1991;917-923.
40. 2 breath test). Z Gastroenterol. 27:1989;624-628.
41. Fubara ES, Freter R. Protection against enteric bacterial infection by secretory IgA antibodies. J Immunol. 111:1973;395-403.
42. Deitch EA, Sittig K, Li M, Berg R. Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg. 159:1990;79-84.
43. Steffen EK, Berg RD. Relationship between cecal population levels of indigenous bacteria and translocation to the mesenteric lymph nodes. Infect Immun. 39:1983;1252-1259.
44. Deitch EA, Bridges W, Baker J, Ma J-W, Ma L, Grisham MB, Granger DN, et al. Hemorrhagic shock-induced bacterial translocation is reduced by xanthine oxidase inhibition or inactivation. Surgery. 104:1988;191-197.
45. Hamdani R, Young S, Runyon BA. Increased bacterial translocation in cirrhotic rats undergoing hemorrhagic shock. Gastroenterology. 106:1994;A904.
46. Smith H. Virulence determinants of Escherichia coli: present knowledge and question. Can J Microbiol. 38:1992;747-752.